|
J Biol Chem, Vol. 274, Issue 48, 34036-34044, November 26, 1999
Lipid-dependent Activation of Protein Kinase C- by
Normal Alcohols*
Yu-Ming A.
Shen ,
Olga I.
Chertihin,
Rodney L.
Biltonen, and
Julianne J.
Sando§
From the Department of Pharmacology and the Biophysics Program and
the Cancer Center, The University of Virginia Health Sciences Center,
Charlottesville, Virginia 22903
 |
ABSTRACT |
Significant stimulation of protein kinase C-
(PKC ) by n-alcohols was observed in characterized lipid systems
composed of phosphatidylcholine/phosphatidylserine/dioleoylglycerol
(PC/PS/DO). The logarithm of the alcohol concentrations to achieve
half-maximal PKC stimulation (ED50) and of the
maximal PKC stimulation by alcohols were both linear functions of
alcohol chain length, consistent with the Meyer-Overton effect. Binding
of phorbol esters to PKC was not significantly affected by octanol.
Octanol increased, up to 4-fold, the affinity of PKC binding to the
lipid bilayers in both the absence and presence of DO. However, octanol
increased PKC activity much more significantly than it enhanced binding of the enzyme to the lipid bilayers, suggesting that the stimulation of
PKC is not merely a reflection of the increase in PKC bilayer binding
affinity. 31P NMR experiments did not reveal formation of
non-lamellar phases with octanol. Differential scanning calorimetry
suggested that alcohols, like diacylglycerol, induce formation of
compositionally distinct domains and the maximal enzyme activity with
alcohol resided roughly in the putative domain-coexistence region.
These results suggest that alcohols are mimicking diacylglycerol in activating PKC, not by binding to the high affinity phorbol ester binding site, but by altering lipid structure and by enhancing PKC-bilayer binding.
 |
INTRODUCTION |
Despite extensive research in the past century, the mechanism of
anesthesia is not well understood and the site(s) of action of
anesthetics is still open to question (1, 2). A common feature of
anesthetic action is the modulation of electrical signaling which is
accomplished by altering membrane conductance through ion channels or
ion channel-linked receptors (3). Two general hypotheses are proposed
to account for the anesthetic actions on these membrane-associated
protein systems (1, 3, 4). The protein binding hypothesis argues that
anesthetics bind directly to hydrophobic regions of specific protein
receptors. The membrane perturbation hypothesis argues that anesthetics
alter physical properties of the membrane that are necessary for the
normal operation of various membrane-associated proteins.
Protein kinase C (PKC)1
phosphorylates and regulates many of the membrane proteins that have
been implicated in pathways affected by anesthetics (5-8), and both
general and local anesthetics have been shown to modulate PKC activity
(9-12). Moreover, PKC requires amphipathic molecules like
diacylglycerol (DAG) and phosphatidylserine (PS) as cofactors that may
activate PKC by both direct binding and by altering the physical
properties of the membrane. Many anesthetics are amphipathic molecules
which have been proposed to bind to PKC at certain sites (10) as well
as to perturb the lipids in the bilayer (3). Thus PKC is a potential
target of anesthetic action and a model protein for testing both the
protein binding hypothesis and the membrane perturbation hypothesis.
PKC is a family of membrane-associated, serine/threonine kinases
present in all tissues and especially abundant in the central nervous
system (13). The PKC family consists of at least 11 isozymes which
require negatively charged phospholipids (among which PS is much more
effective than others), and for some of them, DAG and Ca2+
to achieve full activation (14). Phorbol esters can replace the DAG
requirement (15). In addition, the enzymes can be activated in a
lipid-independent manner by protamine sulfate. While the role of
cofactors in the PKC activation process is not clearly understood, a
variety of studies has argued that physical properties of the lipid
bilayers are important for the activation mechanism (16). The physical
properties of lipid bilayers that are most important in PKC activation
have not been elucidated. Those that have been suggested include
lateral heterogeneity or domain formation (17-19), head group spacing
(20, 21), lipid bilayer curvature (22), and tendency of the bilayer
lipid to form non-bilayer phases (22, 23). The surface potential of
lipid bilayers also can influence activation by, for example,
sequestering Ca2+ on the membrane surface (24, 25). Since
anesthetics can alter many of these membrane properties (12, 26-28),
it is our working hypothesis that anesthetics affect PKC activity, at
least in part, by their effects on membrane physical properties, and
that the anesthetic-modulated enzyme directly or indirectly regulates
the ion channels involved in anesthesia.
Effects of anesthetics on PKC activation have been noted since the
early 1980s (29), but the mechanism of and even the direction of the
effects have remained elusive. Lester and Baumann (30) demonstrated
stimulation of PKC by alcohols in the presence of phosphatidylcholine/phosphatidylserine (PC/PS) vesicles (30). Hemmings
and Adamo (31) noted that varying anesthetic effects could be obtained
in different lipid systems. Slater et al. (32) showed that
interaction of n-alcohols and general anesthetics with PKC results
in dramatically different effects on protamine sulfate-activated enzyme
activity versus lipid activated activity. Furthermore, the
effects of the n-alcohols on lipid-associated PKC activity differ
markedly depending on whether the activity is induced by diacylglycerol
or phorbol ester and are dependent upon n-alcohol chain length (10,
32).
We have examined the effects of several alcohol anesthetics on PKC
activity and membrane binding in characterized lipid systems that
support PKC activity and mimic many features of the cellular membrane.
The saturated lipids DMPC and DMPS were used in this study so that the
phase behavior of these defined lipid binary and ternary systems at
various alcohol concentrations could be studied by differential
scanning calorimetry (DSC). More physiological unsaturated lipid
systems also were examined and similar effects were observed. The
modulation of PKC activity by alcohols appears to be associated with
alcohol effects on lipid structure, possibly via the induction of
lateral heterogeneity or domain formation.
 |
EXPERIMENTAL PROCEDURES |
Materials--
1,2-Dimyristoyl-sn-glycerol-3-phosphatidylcholine
(DMPC), 1,2-dimyristoyl-sn-glycerol-3-phosphatidylserine
(DMPS), 1,2-dipalmitoyl-sn-glycerol-3-phosphatidylcholine (DPPC), 1,2-dipalmitoyl-sn-glycerol-3-phosphatidylserine
(DPPS), 1-palmitoyl,
2-oleoyl-sn-glycerol-3-phosphatidylcholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylserine
(POPS), 1,2-dioleoyl-sn-glycerol (DO), and
dansyl-phosphatidylethanolamine (dansyl-PE) were from Avanti Polar
Lipids (Birmingham, AL). All of the lipids were greater than 99% pure
as determined by thin-layer chromatography on Adsorbosil-Plus plates
from Alltech Associates, Inc. (Deerfield, IL) using the solvent systems
described previously (19). MOPS, calcium chloride, potassium chloride,
and EGTA were Chemika grade and the magnesium chloride was puriss grade
from Fluka Chemical Corp. (Ronkonkoma, NY). [ -32P]ATP
(7000 Ci/mmol) was from ICN Pharmaceuticals, Inc. (Costa Mesa, CA).
[20-3H]Phorbol 12,13-dibutyrate (10-20 Ci/mmol) was from
NEN Life Science Products Inc. (Boston, MA). Lysine-rich histone (type
III-s), ATP, and phorbol esters were from Sigma. Octanol, heptanol,
hexanol, pentanol, and butanol were also from Sigma. Chloroform,
methanol, and benzene were high performance liquid chromatography grade from Fisher Scientific Co. (Pittsburgh, PA). Grace's culture medium, yeastolate, lactalbumin, and fetal calf serum for culture of Sf9 insect cells were from Life Technologies, Inc. (Grand Island, NY).
Purification of Protein Kinase C--
Sf9 insect cells
(~2 × 106 cells/ml in spinner culture) were
infected with a PKC baculovirus expression construct kindly provided by Drs. P. Parker, S. Stabel, and D. Fabbro. Infected cells were harvested when the viability dropped to approximately 85%. PKC was
purified from the cytosol by sequential chromatography on Q-Sepharose
and phenyl-Sepharose columns, both from Amersham Pharmacia Biotech.
Enzyme concentration was determined by assay of phorbol ester binding
as described previously (33) and enzyme purity was confirmed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver
staining and Western blotting using PKC -specific rabbit polyclonal
antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz. CA). The
purified PKC was then stored in 30% glycerol and 20 mM
MOPS at 75 °C. Enzyme was thawed and diluted with MOPS/KCl buffer
just prior to the kinase assays. The enzyme remained 90% intact after
incubation for 1 h at 35 °C as described previously (19).
Preparation of Lipid Vesicles--
The concentration of lipid
stock solutions in chloroform was periodically determined by phosphate
assay as described previously (34). Phospholipids and DO stored in
chloroform were mixed together at the desired molar ratios and dried
thoroughly under nitrogen then under vacuum for at least 1 h. The
lipids were then lyophilized from benzene/methanol (19/1, v/v) for a
minimum of 12 h in the dark. Each dried sample was hydrated in 20 mM MOPS, 100 mM KCl, 100 µM EGTA,
pH 7.2 (MOPS/KCl buffer). Each sample was vortexed extensively above
the main transition temperature for 20 min to make multilamellar
vesicle (MLVs) dispersions. MLVs were subsequently extruded using a
hand microextruder (Avanti Polar Lipids) to make large unilamellar
vesicles (LUVs), as described (19). All lipid vesicles were stored in
the dark under an argon atmosphere at room temperature.
Assay of Protein Kinase C Activity--
Kinase activity was
assessed by the ability of the enzyme to incorporate
[ -32P]ATP into histone. The reaction mixture (75 µl
total) contained 5 mM MgCl2, 300 µM CaCl2, 0.2 mg/ml lysine-rich histone, 40 µM ATP spiked with [ -32P]ATP to 1.6-3.7
Ci/mmol, 5 nM PKC , 20 mM MOPS, 100 mM KCl, 100 µM EGTA, pH 7.2, 1 mM
lipids, and alcohols at concentrations as indicated in the figure
legends. The reaction was terminated after 4 min at 35 °C, 5-7 min
at 30 °C, or 1 h at 4 °C by spotting 60 µl of the reaction
mixture onto Whatman P-81 ion exchange paper (Whatman International,
Maidstone, United Kingdom). The papers were washed three times in 50 mM NaCl to remove unreacted ATP and then dried. Bound
radioactivity was quantitated by measuring the Cerenkov radiation on a
Beckman scintillation counter.
Assay of PKC-Phorbol Ester Binding--
Phorbol ester binding
was assessed by the ability of [20-3H]phorbol
12,13-dibutyrate (PDBu) to bind to PKC . The reaction mixture (75 µl total) contained 5 mM MgCl2, 300 µM CaCl2, 1 mg/ml bovine serum albumin, 2 mM dithiothreitol, 40 nM
[20-3H]PDBu, MOPS/KCl buffer, 5 nM PKC, 1 mM lipids, with 1.5 µM non-labeled PDBu or
0.15% ethanol vehicle, and alcohols at concentrations as indicated in
the figure legends. The reaction was conducted for 5 min at 30 °C or
1 h at 4 °C, and bound [20-3H]PDBu was separated
from free PDBu by rapid passage through Whatman 934-AH glass fiber
filters. The filters were washed 3 times with iced phosphate-buffered
saline (0.15 M NaCl, 8.3 mM NaHPO4,
1.4 mM NaH2PO4), and counted in a
Beckman scintillation counter. The specific binding of PDB to PKC was
calculated as the difference between binding in the presence and
absence of excess unlabeled PDB.
Binding of PKC to the Lipid Bilayers--
Affinity of PKC
binding to the lipid bilayers was estimated using fluorescence energy
transfer from tryptophans in PKC to a dansyl-PE probe with a SLM 8100 fluorometer (SLM-Aminco, Urbana, IL), as modified from Bazzi and
Nelsestuen (35). The excitation and the emission wavelengths were 283 and 510 nm, respectively. Large unilamellar vesicles (LUVs) containing
PC/PS/DO and 2 mol % dansyl-PE at various lipid concentrations were
incubated with 33 or 67 nM PKC. The experiments were
carried out in the same buffer as in the PKC activity assay but histone
and ATP were omitted.
31P Nuclear Magnetic Resonance
Spectroscopy--
MLVs (20 mM total lipid) were prepared
with hydrating buffer containing 50% (v/v) D2O. After a
minimum of 2 days of hydration, each sample was transferred to a 10-mm
diameter NMR tube (Wilmad Glass Co., Buena, NJ). Proton-decoupled free
induction decays were collected at 30 °C using a Varion 500 Unity
Plus spectrometer operating at 202.4 MHz with the following instrument
settings: sweep width, 30 kHz; pulse width, 20 µs; acquisition time,
0.41 s; receiver delay, 0.65 s; number of transients, 10,800. An exponential multiplication corresponding to line broadening of 10 Hz
was applied to the accumulated free induction decays before Fourier transformation.
Differential Scanning Calorimetry--
Excess heat capacity
measurements of lipid and lipid-alcohol dispersions (1.4 ml of 5 mM total lipid) were performed on a MicroCal MC-2 (Microcal
Inc., Northampton, MA) differential scanning calorimeter at a nominal
scan rate of 10 °C/h. The experimental data were analyzed with the
MicroCal's Origin graphic software program.
Determination of Partition Coefficient--
Partition
coefficients of alcohols in DMPC/DMPS/DO systems were determined by
injection titration calorimetry (36) and by measuring the depression of
the gel-fluid transition temperature (37), as described elsewhere.
Injection titration calorimetry was performed on a MicroCal Omega
calorimeter. Solvent blanks or lipids (5 mM) combined with
alcohol were injected into alcohol solutions at 35 or 4 °C with an
injection volume of 30 µl for a duration of 20 s. The syringe
spin rate was 300 rpm. The free alcohol concentration in an
alcohol-lipid-water suspension was determined by a solvent null method,
heat is absorbed (released) if the free alcohol concentration in the
cell is higher (lower) than that in the suspension; when the
concentration in the cell matches the free concentration in the
suspension, no heat is generated upon mixing. The freezing point
depression method was used to obtain the difference between the
partition coefficients of the alcohol into lipids in the fluid and gel
state, using the transition temperature shift induced by alcohol. The
relationship between the difference of partition coefficients and the
shift of the phase transition temperature is,
|
(Eq. 1)
|
where Tm and Tm* are the
transition temperatures in the absence and presence of alcohol,
respectively, Kp,f and Kp,g are
the mole fraction partition coefficients of the alcohol in fluid and
gel state lipids, respectively; R is the gas constant;
H° is the enthalpy per mole of lipid that undergoes a
gel to fluid phase transition in the absence of alcohols; Xa,w is the mole fraction of alcohol in the aqueous
solution at Tm*.
 |
RESULTS |
Alcohols Activate PKC in DMPC/DMPS/DO--
The effect of alcohols
on PKC activation was examined first in DMPC/DMPS/DO ((80-X)/20/X). PKC
activity increased from 0 to 25-30 mol % DO and decreased above 30 mol % DO (data not shown). Addition of alcohols to this lipid system
increased PKC activity (Fig. 1). In the
presence of 15 and 25 mol % DO, alcohols activated PKC synergistically
with DO until maximal enzyme activity was achieved. With shorter chain
alcohols, PKC activation decreased significantly at higher alcohol
concentrations (Fig. 1, D and E). Even in the
absence of DO, high concentrations of alcohols activated PKC. With
longer chain alcohols (Fig. 1, A-C), this activation was
greater than that achieved with 25 mol % DO, which maximally activated
PKC in the absence of alcohol (see above).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
PKC activity as a
function of alcohol concentration in DMPC/DMPS/DO ((80-X)/20/X).
PKC activity was assayed in DMPC/DMPS/DO = 80/20/0 ( ),
65/20/15 ( ), or 55/20/25 ( ) MLVs with various concentrations of
octanol (A), heptanol (B), hexanol
(C), pentanol (D), and butanol (E) at
30 °C for 5 min. The total lipid concentration was 1 mM.
PKC activity is expressed as the fold increase in enzyme activity
compared with 25 mol % DO in the absence of alcohols. Alcohols were
equilibrated with the lipids for at least 12 h before the
experiments. Values are means ± S.E. for triplicate determinations
from a single experiment representative of two to four independent
experiments depending on the alcohol.
|
|
The alcohol concentration to achieve half-maximal stimulation of PKC
activity (ED50) correlated quantitatively with the chain length of the alcohol (Fig.
2A), with the longer chain
alcohols requiring lower concentrations for half-maximal activation of PKC. For each alcohol, the ED50 was smaller in the presence
of DO than in the absence of DO, but the slope of the log
ED50 versus chain length appeared to be
invariant. Since the alcohol chain length correlates linearly with the
logarithm of alcohol partition coefficient between lipids and buffer, a
quantitative correlation between the ED50 and the partition
coefficient of alcohols was obtained as expected (inset of
Fig. 2A).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
Alcohol concentration for half-maximal
PKC stimulation and maximal PKC activity as a
function of alcohol carbon chain length. A, the alcohol
concentration that half-maximally stimulated PKC (ED50)
is shown for DMPC/DMPS/DO = 80/20/0 ( ), 65/20/15 ( ), or
55/20/25 ( ) as a function of alcohol acyl chain length. The
ED50 as a function of alcohol partition coefficient is
shown in the inset. B, the fold increase in
maximal PKC activity with alcohols over that with 25 mol % DO without
alcohols is plotted as a function of acyl carbon chain length for
DMPC/DMPS/DO = 80/20/0 ( ), 65/20/15 ( ), and 55/20/25 ( ).
ED50 and maximal PKC activity for each alcohol were
determined from Fig. 1. Membrane/water partition coefficients for
alcohols were determined by isothermal titration calorimetry as
described under "Experimental Procedures." Lines were
calculated by linear regression.
|
|
A similar correlation was obtained between the alcohol chain length and
the maximal alcohol-enhanced PKC activity, defined as the fold
stimulation of maximal PKC activity with alcohol over that with 25 mol
% DO without alcohol (Fig. 2B). The maximal
alcohol-enhanced PKC activity was greater with higher DO concentrations
for individual alcohols, but maximal PKC activity appeared to increase
with alcohol chain length more rapidly at lower DO concentrations, as
indicated by the increase of the slope when DO mol % was decreased
(Fig. 2B).
Octanol Activates PKC in DPPC/DPPS/DO and POPC/POPS/DO
Systems--
To determine whether the phospholipid composition, like
the DO mol %, affected alcohol activation of PKC, we examined two additional lipid systems. DPPC/DPPS/DO was selected because this system
is similar to DMPC/DMPS/DO with saturated acyl chains on the
phospholipids, but it provides a gel state environment because its
gel-liquid crystalline phase transition occurs at temperatures higher
than the PKC activity assay temperature (30 °C). POPC/POPS/DO was
selected because this system contains lipids with saturated and
unsaturated acyl chains that are similar to cell membrane lipids and
exist in the fluid state under our assay conditions. It also has been
shown to activate more effectively than DMPC/DMPS/DO at low DO
concentrations (20). This system also supports PKC-phorbol ester
binding which will be utilized in later experiments whereas neither of
the saturated phospholipid systems (DMPC/DMPS or DPPC/DPPS) supports
significant phorbol ester binding. We selected octanol as a
representative alcohol to use with the two lipid systems because it was
the most potent alcohol in stimulating PKC activity in the DMPC/DMPS/DO system.
DPPC/DPPS/DO and POPC/POPS/DO were first characterized for PKC
activating ability at various concentrations of DO from 0 to 25 mol % (data not shown). DPPC/DPPS/DO supported PKC activity with increasing
DO from 0 to 10 mol %, with maximal PKC activity maintained until 20 mol %. PKC activity decreased when DO was higher than 20 mol %.
POPC/POPS/DO required much less DO (1 mol %) to maximally activate
PKC, similar to the fully unsaturated DOPC/DOPS/DO system studied
previously (20). The enzyme was nearly inactive at 0 mol % DO, then
was activated linearly from 0 to 1 mol % DO, and maintained maximal
activity from 1 to 25 mol % DO (data not shown).
Addition of octanol to the DPPC/DPPS/DO system enhanced PKC activity
similarly to that in DMPC/DMPS/DO (cf. Fig. 1A
and Fig. 3A). In the presence
of 15 or 25 mol % DO, low concentrations of octanol stimulated PKC
activity significantly and synergistically with DO. The stimulation was
maximal at 2.5 mM octanol and decreased at higher octanol
concentration. As with the DMPC/DMPS system, high octanol
concentrations activated PKC in the DPPC/DPPS system in the absence of
DO. However, a higher octanol concentration was required to obtain the
onset of PKC stimulation in the DPPC/DPPS system in the absence of DO
(~2.5 mM octanol for DPPC/DPPS versus ~1
mM octanol for the DMPC/DMPS system).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
PKC activity as a
function of octanol concentration in different lipid systems.
PKC activity was assayed with various octanol concentrations in:
A, DPPC/DPPS/DO = 80/20/0 ( ), 65/20/15 ( ), or
55/20/25 ( ), and B, POPC/POPS/DO = 80/20/0 ( ),
79.5/20/0.5 ( ), or 75/20/5 ( ) MLVs at 30 °C for 5 min. Total
lipid concentration was 1 mM. PKC activity is expressed
as the fold increase in the enzyme activity compared with 25 mol % DO
for DPPC/DPPS/DO and 5 mol % DO for POPC/POPS/DO in the absence of
octanol. Values are mean ± S.E. for triplicate determinations
from a single experiment representative of two to four independent
experiments.
|
|
In the POPC/POPS/DO system (Fig. 3B), PKC activity increased
with octanol concentration and did not seem to reach a maximum as
observed with the DMPC/DMPS/DO and DPPC/DPPS/DO systems. In both the
absence and presence of DO, even the lowest octanol concentrations caused significant increases in PKC activity. The presence of DO
provided a small increase in the enzyme activity, but did not alter the
dependence of PKC activation on octanol. The synergistic effect of DO
and octanol on maximal PKC activation was not as prominent as with the
saturated lipid systems.
The effects of alcohols on PKC activation are similar to those of DAG
in three respects. First, in the saturated lipid system higher alcohol
or DAG concentration is required to significantly activate PKC. Second,
the enzyme activity exhibits a maximum as a function of alcohol or DAG
concentration. Third, in the unsaturated lipid system much lower
concentrations of either alcohol or DAG are required to activate
PKC.
Octanol Does Not Affect High Affinity Binding of Phorbol Esters to
PKC--
The observation that alcohols activate PKC in the absence of
DO raised the possibility that alcohols might activate PKC by interacting with the binding sites for DO on the enzyme, presumably the
cysteine-rich domains which also bind phorbol esters with high
affinity. To test this hypothesis, we examined the effects of octanol
on the binding of phorbol esters to PKC.
In POPC/POPS (50/50) MLVs, PDBu bound to 5 nM PKC with an
apparent dissociation binding constant (Kd) of about
20 nM (Fig. 4A).
We had to reduce the concentration of POPC from 80 to 50 mol % because
we found that the nonspecific binding of PDBu to the membrane was
greatly enhanced when POPC is greater than 70% (data not shown). High
concentrations of octanol (1 and 2 mM) did not have
inhibitory effects on the binding over a range of PDBu concentrations
up to 10-fold the apparent Kd (Fig. 4A).
Instead, octanol appeared to slightly enhance maximal PDB binding to
PKC. To further investigate this enhancement, a series of octanol
concentrations were applied to POPC/POPS (50/50) with 75 nM
PDBu, under which conditions the high affinity phorbol ester-binding
site of PKC was essentially saturated. No significant effect on the
degree of PDB-PKC binding was observed (Fig. 4B). The
inset of Fig. 4 shows that octanol activated PKC over this alcohol concentration range in this POPC/POPS (50/50) system as it did
in POPC/POPS (80/20) (Fig. 3). Similar results were found in the
presence of 5 mol % DO (POPC/POPS/DO (45/50/5)) with dramatic activation of PKC by octanol but with no effect on PDB binding to PKC
(data not shown). PKC- has a putative second phorbol ester-binding site with a Kd at least 2 orders of magnitude higher than that for the high affinity binding site (38). Due to high nonspecific membrane binding of PDBu at high concentrations, our binding assay was not able to assess low affinity binding of phorbol ester to PKC.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of octanol on the specific binding of
phorbol ester to PKC . The specific
binding of [3H]PDBu to PKC (5 nM) was
determined in POPC/POPS = 50/50 MLVs (1 mM).
A, binding of PKC to [3H]PDBu with 0 ( ),
1 ( ), and 2 mM ( ) octanol. The reaction was conducted
at 4 °C for 2 h. B, binding of PKC to
[3H]PDBu (72 nM) was assayed as a function of
octanol concentration at 30 °C for 6 min. The enzyme activity as a
function of octanol concentration assayed under the same conditions is
shown in the inset. Values are means ± S.E. for four
to six replicate determinations from a single experiment representative
of three independent experiments.
|
|
Octanol Increases Membrane Binding of PKC in the DMPC/DMPS
System--
PKC has to be associated with the bilayer to achieve its
highest activity. PKC activity can be enhanced if the fraction of membrane-bound enzyme is increased and DAG has been shown to increase the affinity of PKC-bilayer binding by at least 1 order of magnitude (39). To test the possibility that alcohols promote PKC activity by
increasing the fraction of bilayer-bound PKC, octanol was applied to
the DMPC/DMPS/DO system and bilayer binding of PKC was detected by
measuring fluorescence energy transfer from the Trp in PKC- to
dansyl-phosphatidylethanolamine (dansyl-PE) probes incorporated into
the vesicles. Dansyl-PE at high concentration ( 10 mol %) has been
shown to alter membrane structure and in turn to activate PKC (39). In
this experiment we used 2 mol % which did not affect PKC activity
(data not shown).
In the absence of DO, the binding was poor and little fluorescence
energy transfer was measurable (Fig.
5A). An assay of competitive binding between DMPC/DMPS (80/20) and DMPC/DMPS/DO (72.5/20/7.5) vesicles provided an estimate of the apparent Kd to
be greater than 450 µM in the absence of DO (data not
shown). This method measures the apparent Kd of
reference vesicles (VR) in the absence and the
presence of the vesicles of interest (VI). The
apparent Kd,I of
VI is estimated as
[LI]/(Kd,RI/Kd,R-1), where [LI] is the concentration of
VI and Kd,RI and Kd,R are the apparent
dissociation constants of VR in the presence and
absence of VI, respectively. When 3 mM
octanol was added to DMPC/DMPS (80/20), Kd was
estimated to be ~170 µM (Fig. 5A). LUVs were
used in the fluorescence energy transfer experiments whereas MLVs were
used in PKC activity assays shown in Fig. 1. About 10% of the total
lipids are in the outermost layer of MLVs with which PKC is associated.
With the 1 mM MLVs used in Fig. 1, PKC is mostly unbound to
the bilayers in the absence of DO and octanol because the
Kd (>450 µM) is much greater than the
accessible MLV concentration (100 µM), whereas in the
presence of 3 mM octanol some fraction of the enzyme is
bound to the bilayer because the Kd (~170 µM) is close to the accessible MLV concentration. These
results suggest that in the absence of DO, octanol may, at least in
part, promote PKC activity by enhancing the membrane binding of the enzyme. They cannot account for the fact that the maximal activity in
the presence of octanol is 2-4-fold greater than the maximal activity
obtained with DO alone.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of octanol on binding of PKC to the
membrane. Binding of PKC to the membrane was determined using
fluorescence energy transfer from PKC to the probe dansyl-PE in
DMPC/DMPS/DO LUVs. A, binding of PKC to DMPC/DMPS/DO = 80/20/0 as a function of total lipid concentration in the absence ( )
and in the presence ( ) of 3 mM octanol. B,
binding of PKC to DMPC/DMPS/DO = 72.5/20/7.5 as a function of
total lipid concentration in the absence ( ) and in the presence of
600 µM ( ) and 3 mM ( ) octanol.
C, binding of PKC to DMPC/DMPS/DO = 65/20/15 as a
function of total lipid concentration in the absence ( ) and presence
of 200 µM ( ) octanol. Figures are representative of
two to five independent experiments.
|
|
In the presence of 7.5 mol % DO, the affinity of PKC binding to the
bilayer was increased with the addition of octanol (Fig. 5B). The apparent Kd was reduced by about
2-fold with 0.6 mM octanol (from 5.7 to 3.3 µM) and by about 4-fold with 3 mM octanol
(from 5.7 to 1.6 µM). Octanol activated PKC in this lipid
system (data not shown) as it did in DMPC/DMPS/DO (65/20/15) and
(55/20/25) (Fig. 1A). The ED50 was less than 0.5 mM octanol and 1 mM octanol was able to
maximally stimulate PKC activity by more than 12-fold, about 4-fold
higher than that induced by 25 mol % DO alone.
In DMPC/DMPS/DO (65/20/15), 200 µM octanol was able to
increase the enzyme activity by 3-fold (Fig. 1A) but only
slightly enhanced the affinity of PKC binding to the bilayers (Fig.
5C). A similar result was observed in the DMPC/DMPS/DO
(55/20/25) system (data not shown), although the apparent dissociation
constant Kd was so small ( 2.5 µM)
that changes in Kd would be in the range of errors
of measurement.
Octanol Does Not Induce Micellar or Hexagonal II Phases--
PCs
or PSs with acyl chains shorter than eight carbons can form micelles
and eliminate the requirement for PS or DAG in activating PKC (40).
Bilayers in the cubic phase or with a tendency to form the
HII phase, but not the HII phase itself, have
been proposed to activate PKC (21, 41). To test the hypothesis that
alcohols activate PKC by inducing non-lamellar phases of the lipids,
31P NMR spectroscopy was employed to detect the isotropy of
the DMPC/DMPS/DO systems with octanol. At 30 °C, a typical, broad anisotropic spectrum indicative of a lamellar structure of MLVs of
DMPC/DMPS/DO (80/20/0), (65/20/15), and (55/20/25) was observed. A
small, isotropic peak indicative of a slight contamination (3-5%) by
SUV also was observed on occasion. No nonlamellar isotropic resonances
were observed in any lipid system with the addition of different
octanol concentrations up to the octanol aqueous solubility limit of
4.5 mM (data not shown). Interestingly, octanol acted
similarly to DO in shifting the 31P resonance downfield and
broadening the MLV spectrum. These results suggest that alcohol does
not induce the phospholipids to form nonlamellar phases or regions of
high bilayer curvature.
Octanol and Pentanol Change the Phase Behavior and Induce Lateral
Heterogeneity in DMPC/DMPS System--
Another possible mechanism by
which alcohols may mimic DAG in activating PKC is that they both may
alter the phase behavior of the lipid bilayers. Lipid lateral domain
heterogeneity has been related to PKC activation by DAG (19, 42). To
investigate the effects of alcohols on the phase behavior of the lipid
bilayers, we used DSC and examined the DMPC/DMPS system with octanol
and pentanol (Fig. 6). DSC measures the
excess heat capacity of the lipid system as a function of temperature
and provides direct information about the lipid gel to
liquid-crystalline phase transition temperature (Tm)
and the enthalpy of the phase transition.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of octanol and pentanol on excess
heat capacity functions for DMPC/DMPS LUVs and PKC
activity in the lipids. The excess heat capacity with
various concentrations (mole fractions in the lipids) of octanol
(A) and pentanol (B) as a function of temperature
was determined in DMPC/DMPS = 50/50 LUVs. The thermograms were
up-scans from 2 to 40 °C at 10 °C/h. Lipids (5 mM)
were hydrated in 20 mM MOPS, 100 mM KCl, 100 µM EGTA, pH 7.2. Onset ( ) and offset ( )
temperatures of the gel-fluid phase transition are plotted as a
function of octanol (C) and pentanol (D) mole
fractions in the lipids. Lipid samples with octanol and pentanol were
subsequently used for PKC activity measurements at 4 °C ( ) and
35 °C ( ) and the results are plotted in E and
F. The reaction times for 4 and 35 °C were 1 h and
2.5 min, respectively. PKC activity is normalized to the maximal
activity at each temperature in each alcohol. Partition coefficients
for octanol are 7.4 × 103 and 1.4 × 104 at 4 and 35 °C, respectively, and partition
coefficients for pentanol are 350 and 600 at the two temperatures.
Figures are representative of two to three independent
experiments.
|
|
As octanol or pentanol concentration was increased up to
octanol = 0.29 or pentanol = 0.27 in gel
state lipids, the Tm decreased and the transition
broadened. However, at higher octanol or pentanol concentrations the
Tm continued to decrease but the transition peak
retained its shape with the increase of octanol and became sharper with
the increase of pentanol (Fig. 6, A and B). In
the presence of pentanol the transition exhibited two maxima suggestive
of possible phase separation. The onset and offset temperatures of the
main transition rapidly decreased at lower pentanol concentration and
at a much reduced rate above pentanol = 0.2 and 0.38 for
onset and offset temperatures, respectively. The partial phase diagram,
shown in Fig. 6D, is suggestive of possible lipid demixing
in the presence of pentanol. A similar partial phase diagram for
octanol is less clear (Fig. 6C), although demixing above
octanol = 0.19 0.29 (onset) and 0.36 (offset) is
suggested. The enthalpy change associated with the transition, obtained
from the total area under the transition curve, did not vary
significantly with the concentration of either alcohol (data not
shown). DAG was omitted here to avoid the interference of DAG-induced
alteration of lipid structure, which shares many features with
the alcohol results shown here (19). Nonetheless, the effect of octanol
also was tested in the DMPC/DMPS/DO and DPPC/DPPS/DO systems with 0, 15, and 25 mol % DO and results similar to those in Fig. 6 were
observed (data not shown).
When PKC activity was measured over the same alcohol concentration
range as used in the experiments described in the legends to Fig. 6,
A and B, two effects resembled those of DAG on
PKC activation previously reported (19, 42). First, with both gel
(4 °C) and fluid (35 °C) state lipid bilayers, PKC activity exhibited a maximum at a pentanol concentration that resides roughly in
the putative coexistence region (cf. Fig. 6, D
with F). Second, a lower mole fraction of alcohol in the
lipid was required to activate PKC and achieve maximal enzyme activity
in gel state than in fluid state (Fig. 6, E and
F).
The peak in PKC activity is more pronounced with pentanol than with
octanol (cf. Fig. 6, E and F). It
appears that in gel state lipids with octanol, the enzyme activity
exhibits a plateau, and a decrease of PKC activity is not observed in
either gel or fluid state lipids with octanol. However, Fig. 6,
E and F, show that the dependence of PKC activity on
octanol in the lipid is similar to that on
pentanol in the lipid before the maximal enzyme activity
is achieved. With 5 mM lipids, octanol concentrations above
octanol = 0.42 in gel state (or 9 mM total
octanol concentration, the highest in the experiment) were not
accessible due to the aqueous solubility limit (4.5 mM) of octanol.
 |
DISCUSSION |
Here we report the activation of PKC by several n-alcohols in a
saturated lipid system (Fig. 1) and by octanol in both saturated and
unsaturated lipid systems (Figs. 1A and 3). In both systems alcohols activate PKC synergistically with DO and more effectively than
DO. PKC activity as a function of alcohol concentration in either
saturated or unsaturated lipids resembles that as a function of DO.
As noted previously (19-20, 42-43), the mole % DAG required for
maximal PKC activity is much higher in saturated versus
unsaturated lipid systems. Although these concentrations would appear
to be supraphysiological when expressed as a function of total cellular lipid, it must be remembered that the local concentration of DAG would
be much higher at sites of phospholipase action where PKC might be
activated. Similarly higher alcohol concentrations are required to
activate PKC in the saturated systems (Figs. 1 and 3). Thus like other
lipid-soluble modulators of PKC activity (31, 44), the concentrations
of alcohols required depend on the lipid context.
Our results for octanol and heptanol in DMPC/DMPS/DO ((80-X)/20/X) are
similar to those of Slater et al. (32) in POPC/brain PS/DO
(76/20/4). However, our results for shorter chain alcohols (butanol to
hexanol) demonstrate activation without DO and activation followed by
inhibition with DO, whereas they observed only inhibition of PKC (10,
32). Some differences in lipid compositions (unsaturated mixed lipids
versus saturated or unsaturated mixed lipids here), lipid
vesicle types and concentrations (150 µM LUVs
versus 1 mM MLVs here), and substrates (peptide
corresponding to the consensus sequence of myelin basic protein
versus histone here) exist between their studies and this
one and could be the basis of the difference in the observations.
Lester and Baumann (30) did observe a slight activation of rat brain
PKC with ethanol in 100 µM egg PC/bovine spinal cord
PS/liver DAG (80/20/10) vesicles using histone as substrate.
We have observed that octanol enhances the binding of PKC to lipid
bilayers in both the absence and presence of DO (Fig. 5). This
enhancement appears to account, at least partially, for PKC activation
by octanol in the absence of DO. However, the increase in PKC activity
with 3 mM octanol is at least 2 orders of magnitude greater
than the basal activity whereas the increase of PKC-bilayer binding
affinity is only 3-fold, suggesting that the increased binding is
insufficient to explain the promotion of PKC activity by octanol.
Similarly, in the presence of DO, binding of PKC to the bilayers is
only slightly increased with low concentrations of octanol which
dramatically activate PKC (cf. Figs. 1A and 5). It should be noted, however, that different lipid vesicles are used in
the activity assays (MLVs) and bilayer binding measurements (LUVs) as
well as different enzyme:lipid ratios (5 nM PKC with 1 mM total lipid in kinase assays versus 33 or 67 nM PKC with 3-400 µM lipid in bilayer
binding assays). The enzyme:lipid ratio is higher in the bilayer
binding assays under all conditions even with accounting for the
MLV/LUV difference. Since a peak rather than a plateau occurs in PKC
activity assays as a function of lipid concentration and composition
(43), bilayer binding and activity cannot be compared quantitatively
unless the assays are conducted under identical conditions and this was
not possible here due to the differing sensitivities of the two assays.
One of the two major hypotheses for the mechanism of anesthetic actions
argues for the existence of a specific binding site(s) in a protein for
anesthetics (the specific protein binding model). Since (i) alcohols
mimic DAG in activating PKC and enhancing the binding of PKC to lipid
bilayers and (ii) DAG interacts directly with PKC by binding to one of
the cysteine-rich domains on the enzyme, PKC would be an example of the
specific protein binding model if alcohols bind to the DAG, or more
specifically phorbol ester, the binding sites.
Activation of PKC by alcohols does not seem to be attributable to
the interaction of alcohols with the high affinity phorbol ester-binding site on PKC , as shown in Fig. 4. No significant effect
on PDB-PKC binding is observed with octanol over a wide range of PDB
concentrations (Fig. 4A). There is no competition between
octanol and PDB in binding to PKC over a range of octanol concentrations which dramatically enhance PKC activity (Fig. 4B).
Slater et al. (32) observed that octanol enhances the
interaction of the phorbol ester sapintoxin D with PKC at the high affinity binding site. However, they also observed no effect of butanol
on high affinity binding of sapintoxin D to PKC . They proposed that
DAG and alcohols compete for binding to a putative low affinity phorbol
ester-binding site, and that high affinity binding of phorbol ester is
in turn enhanced by DAG or long chain alcohols but not by short chain
alcohols. They suggested that the activation of PKC by DAG or long
chain alcohols resulted from enhancement of phorbol ester binding to
the high affinity site on the enzyme.
An alternative explanation for the enhancement of high affinity phorbol
ester binding is an increase in PKC bilayer association when DAG or
octanol are present. The apparent dissociation constant (Kd,app) of phorbol esters from the high
affinity site on PKC is determined by the association of PKC with
the bilayer and the interaction of phorbol esters with
bilayer-associated PKC . If some of the enzyme is not bound to the
bilayer, Kd,app will be greater than the
Kd of phorbol ester with bilayer-bound PKC and
any compound that promotes the association of soluble PKC with the
bilayer will decrease Kd,app. On the
other hand, if all of the enzyme is bound to the bilayer,
Kd,app is the same as the
Kd of phorbol ester from bilayer-bound PKC and would
not be affected by any compound that facilitates the bilayer
association process. The Kd,app of
sapintoxin D and PDB binding to PKC in a detergent/lipid mixed
micellar system are ~2.5 and ~20 nM, respectively (45).
However, the Kd,app of sapintoxin D from
PKC ( 100 nM) in the lipid system used by Slater et
al. (32) (POPC/BPS = 4/1 molar ratio, 150 µM)
is 40-fold greater than that in a micellar system, whereas the
Kd,app of PDB from PKC (~20
nM) in our lipid system (POPC/POPS = 1/1 molar ratio,
1 mM) is close to that in the micellar system. This
suggests that PKC is not all bound to the bilayers under the
conditions used in the experiments described by Slater et
al. (32) but that it is mostly associated with the lipid system
described here. In support of this conjecture, it has been shown that
20 mol % PS (used in the Slater et al. (32) report) was
insufficient to support significant PKC binding to the POPC/POPS or egg
PC/BPS systems, while 50 mol % PS (used in the phorbol ester binding
experiments of Fig. 4) was able to facilitate binding of more than 75%
of PKC to the bilayer (39, 46, 47). Octanol can increase the membrane
binding of PKC in the absence and presence of DAG, as shown in Fig. 5,
and DAG is known to promote significantly bilayer association of PKC
(39).
To test the specific protein binding hypothesis for alcohol effects on
PKC, Slater et al. (32) also used protamine sulfate and
observed inhibition of PKC by alcohols, instead of activation as
observed in the presence of lipids. Protamine sulfate is commonly used
in place of lipids to monitor the lipid independent activity of PKC
(48) and Slater et al. (32) suggested that the inhibitory effect involves the direction interaction between PKC and alcohols which attenuates a conformational change of PKC induced by interaction with protamine sulfate (32). It should be noted that protamine sulfate
also can be phosphorylated by PKC and is sometimes used as a PKC
substrate. We have used protamine sulfate to replace lipids and
observed octanol effects on PKC activation in the presence and absence
of histone. Interestingly, phosphorylation of protamine sulfate in the
absence of histone is increased with octanol, whereas the total
phosphorylation of protamine sulfate plus histone is decreased; the
phosphorylation of histone in the presence of protamine sulfate is
therefore decreased with octanol (data not shown). The mechanism of
protamine sulfate activation of PKC is poorly understood and Orr and
Newton (49) have shown that this activator does not induce the same
conformational change in PKC as do lipid activators. Possible
alternative interpretations of the inhibition of PKC by alcohols with
protamine sulfate are disruption of essential protamine sulfate
aggregates (50) by the alcohols or irreversible damage to PKC, as may
occur with some organic solvents in the absence of lipids (16).
The other major hypothesis for the mechanism of anesthetic actions
argues for nonspecific effects on the lipid bilayers (the general
membrane perturbation model). In addition to direct binding to PKC, DAG
plays an important role in changing the physical properties of bilayers
that are important for PKC activation. A relationship between PKC
activity and changes in bilayer physical properties induced by the
DAG-mimicking alcohols would support the general membrane perturbation model.
31P NMR experiments did not reveal formation of any
nonlamellar structures over the octanol concentration range used in our PKC activity assays, arguing that octanol does not activate PKC by
inducing nonlamellar phases like micelles, cubic phase, or HII phase. Epand et al. (21) suggested that the
HII phase itself does not activate PKC, but the propensity
of the lipids to form HII does. This propensity, however,
cannot be revealed by 31P NMR.
Another structural change that alcohols with carbon chains shorter than
7 or 8 may induce in lipid bilayers is interdigitation of the lipids
(51). Alcohol-induced lipid interdigitation can be ruled out here for
two reasons: 1) interdigitation only occurs in gel state lipids but
many of our experiments were conducted with fluid state lipids; 2) more
importantly, the main transition temperature monotonically decreases
with alcohol (e.g. Fig. 6) rather than increases as observed
with alcohol-induced interdigitation (51).
DSC experiments suggest that alcohols, like DAGs (19, 42), may promote
domain formation/demixing in DMPC/DMPS systems (Fig. 6). In the case of
pentanol, a maximal PKC activation was observed with alcohol mole
fractions where maximal coexistence of distinct domains would exist. If
these putative alcohol-induced domains are similar to DAG-induced
domains in facilitating the binding/insertion of PKC to the membrane
and subsequent PKC substrate or PKC-PKC aggregation, then a further
common basis for understanding alcohol and DAG activation of PKC exists.
Although DAG can bind directly to PKC (reviewed in Ref. 16) and is well
known to enhance PKC-bilayer association (39, 46), Dibble et
al. (19, 42) have suggested that DAG also induces lateral
heterogeneity in PC/PS mixtures and that this effect is important for
PKC activation. It was suggested that DAG associates with PC and PS to
form putative DAG-rich domains distinct from the DAG-poor domains. PKC
activity is strongly correlated with the co-existence of the putative
DAG-rich and DAG-poor domains, with maximal enzyme activity occurring
at a DAG mole fraction that creates the maximal interface between the
two domains. Three possible explanations were proposed for this
correlation: 1) PKC might preferentially associate with one type of
domain and cluster on the membrane surface, thus enhancing the
probability of enzyme oligomerization which may relate to PKC
activation; 2) PKC activation might be facilitated by the
binding/insertion of the enzyme at the interface between coexisting
DAG-rich and DAG-poor phases; 3) PKC might be sensitive to the DMPS/DO
mole ratio with either the DO-rich or the DO-poor phase. Recent studies
of PKC activity as a function of mole fraction of PS, lipid
concentration, and enzyme concentration revealed an activity maximum
rather than a plateau, consistent with the possibility that increased
quantities of activating lipid domains serve to dilute out
PKC-substrate and/or PKC-PKC aggregates on the lipid surface (43).
In summary, alcohols can both lower and replace the DAG requirement for
PKC activation in part by enhancing the affinity of enzyme binding to
the bilayers and also in a manner dependent upon bilayer composition.
The latter effect, we suggest, is due to the alcohol-induced formation
of certain types of lipid domains required for PKC activation.
 |
ACKNOWLEDGEMENT |
We thank Dr. Jeffery Ellena for assistance
with the NMR experiments.
 |
FOOTNOTES |
*
This work was supported by Health and Human Services Grants
R01 GM31184, P01 GM 47525, and R01 GM 59205.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Member of the Biophysics Graduate Program at the University of Virginia.
§
To whom correspondence should be addressed: Dept. of Pharmacology,
University of Virginia Health Sciences Center, Box 448, Charlottesville, VA 22908. Tel.: 804-924-5020; Fax: 804-982-3878; E-mail: jjs@virginia.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
PKC, protein kinase
C;
DAG, diacylglycerol;
DMPC, dimyristoylphosphatidylcholine;
DMPS, dimyristoylphosphatidylserine;
DO, dioleoyl-sn-glycerol;
DOPC, dioleoylphosphatidylcholine;
DOPS, dioleoylphosphatidylserine;
DPPC, dipalmitoylphosphatidylcholine;
DPPS, dipalmitoylphosphatidylserine;
DSC, differential scanning calorimetry;
LUV, large unilamellar vesicles;
MLV, multilamellar vesicles;
MOPS, 3-(N-morpholino)propanesulfonic acid;
PC, phosphatidylcholine;
PDBu, phorbol 12,13-dibutyrate;
PE, phosphatidylethanolamine;
POPC, 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine;
POPS, 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylserine;
PS, phosphatidylserine.
 |
REFERENCES |
| 1.
|
Ueda, I.,
and Kamaya, H.
(1984)
Anesth. Analg.
63,
929-945[Free Full Text]
|
| 2.
|
Franks, N. P.,
and Lieb, W. R.
(1994)
Nature
367,
607-614[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hille, B.
(1980)
in
Progress in Anesthesiology, Vol. 2: Molecular Mechanism of Anesthesia
(Fink, B. R., ed)
, pp. 1-5, Raven Press, New York
|
| 4.
|
Dodson, B. A.,
and Moss, J.
(1984)
Mol. Cell. Biochem.
64,
97-103[Medline]
[Order article via Infotrieve]
|
| 5.
|
Shearman, M. S.,
Sekiguchi, K.,
and Nishizuka, Y.
(1989)
Pharmacol. Rev.
41,
211-237[Abstract]
|
| 6.
|
Nishizuka, Y.,
Shearman, M. S.,
Oda, T.,
Berry, N.,
Shinomura, T.,
Asaoka, Y.,
Ogita, K.,
Koide, H.,
Uikkawa, U.,
Kishimoto, A.,
Kose, A.,
Saito, N.,
and Tanaka, C.
(1991)
in
Elsevier Science Publisher
(Gispen, W. H.
, and Routtenberg, A., eds)
, pp. 125-141, Elsevier Science Publisher B. V., Amsterdam, Netherlands
|
| 7.
|
Huganir, R. L.,
and Greengard, P.
(1990)
Neuron
5,
555-567[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Hemmings, H. C. J.,
Nairn, A. C.,
McGuinness, T. L.,
Huganir, R. L.,
and Greengard, P.
(1989)
FASEB J.
3,
1583-1592[Abstract]
|
| 9.
|
Hemmings, H. C. J.,
and Adamo, A. I.
(1996)
Anesthesiology
84,
652-662[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Slater, S. J.,
Cox, K. J.,
Lombardi, J. V.,
Ho, C.,
Kelly, M. B.,
Rubin, E.,
and Stubbs, C. D.
(1993)
Nature
364,
82-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Oda, A.,
Druker, B. J.,
Ariyoshi, H.,
Smith, M.,
and Salzman, E. W.
(1995)
Am. J. Physiol.
269,
C118-C125[Abstract/Free Full Text]
|
| 12.
|
Trudell, J. R.,
Costa, A. K.,
and Hubbell, W. L.
(1991)
Ann. N. Y. Acad. Sci.
625,
743-746[Medline]
[Order article via Infotrieve]
|
| 13.
|
Nishizuka, Y.
(1992)
Science
258,
607-614[Abstract/Free Full Text]
|
| 14.
|
Dekker, L. V.,
and Parker, P. J.
(1994)
Trends Biochem. Sci.
19,
73-77[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Castagna, M.,
Takai, Y.,
Kaibuchi, K.,
Sano, K.,
Kikkawa, U.,
and Nishizuka, Y.
(1982)
J. Biol. Chem.
257,
7847-7851[Abstract/Free Full Text]
|
| 16.
|
Sando, J. J.,
Maurer, M. C.,
Bolen, E. J.,
and Grisham, C. M.
(1992)
Cell. Signal.
4,
595-609[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Bazzi, M. D.,
and Nelsestuen, G. L.
(1991)
Biochemistry
30,
7961-7969[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Yang, L.,
and Glaser, M.
(1995)
Biochemistry
34,
1500-1506[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Dibble, A. R.,
Hinderliter, A. K.,
Sando, J. J.,
and Biltonen, R. L.
(1996)
Biophys. J.
71,
1877-1890[Medline]
[Order article via Infotrieve]
|
| 20.
|
Bolen, E. J.,
and Sando, J. J.
(1992)
Biochemistry
31,
5945-5951[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Epand, R. M.,
Epand, R. F.,
Leon, B. T.,
Menger, F. M.,
and Kuo, J. F.
(1991)
Biosci. Rep.
11,
59-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Senisterra, G.,
and Epand, R. M.
(1993)
Arch. Biochem. Biophys.
300,
378-383[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Goldberg, E. M.,
Lester, D. S.,
Borchardt, D. B.,
and Zidovetzki, R.
(1994)
Biophys. J.
66,
382-393[Medline]
[Order article via Infotrieve]
|
| 24.
|
Trudell, J. R.,
Costa, A. K.,
and Csernansky, C. A.
(1989)
Biochem. Biophys. Res. Commun.
162,
45-50[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Moris, M. E.,
and McLaughlin, S.
(1992)
in
Protein Kinase C, Current Concepts and Future Perspectives
(Lester, D.
, and Epand, R. M., eds)
, pp. 157-180, Hills Horwood Limited, Chichester, England
|
| 26.
|
Ho, C.,
Kelly, M. B.,
and Stubbs, C. D.
(1994)
Biochim. Biophys. Acta
1193,
307-315[Medline]
[Order article via Infotrieve]
|
| 27.
|
Bottner, M.,
and Winter, R.
(1993)
Biophys. J.
65,
2041-2046[Medline]
[Order article via Infotrieve]
|
| 28.
|
Jorgensen, K.,
Ipsen, J. H.,
Mouritsen, O. G.,
Bennett, D.,
and Zuckermann, M. J.
(1991)
Biochim. Biophys. Acta
1067,
241-253[Medline]
[Order article via Infotrieve]
|
| 29.
|
Mori, T.,
Takai, Y.,
Minakuchi, R., Yu, B.,
and Nishizuka, Y.
(1980)
J. Biol. Chem.
255,
8378-8380[Abstract/Free Full Text]
|
| 30.
|
Lester, D. S.,
and Baumann, D.
(1991)
Eur. J. Pharmacol.
206,
301-308[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Hemmings, H. C. J.,
and Adamo, A. I.
(1994)
Anesthesiology
81,
147-155[Medline]
[Order article via Infotrieve]
|
| 32.
|
Slater, S. J.,
Kelly, M. B.,
Larkin, J. D.,
Ho, C.,
Mazurek, A.,
Taddeo, F. J.,
Yeager, M. D.,
and Stubbs, C. D.
(1997)
J. Biol. Chem.
272,
6167-6173[Abstract/Free Full Text]
|
| 33.
|
Sando, J. J.,
and Young, M. C.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
2642-2646[Abstract/Free Full Text]
|
| 34.
|
Morrison, W. R.
(1964)
Anal. Biochem.
7,
218-224
|
| 35.
|
Bazzi, M. D.,
and Nelsestuen, G. L.
(1987)
Biochemistry
26,
115-122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Zhang, F.,
and Rowe, E. S.
(1992)
Biochemistry
31,
2005-2011[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Kaminoh, Y.,
Tashiro, C.,
Kamaya, H.,
and Ueda, I.
(1988)
Biochim. Biophys. Acta
946,
215-220[Medline]
[Order article via Infotrieve]
|
| 38.
|
Slater, S. J.,
Ho, C.,
Kelly, M. B.,
Larkin, J. D.,
Taddeo, F. J.,
Yeager, M. D.,
and Stubbs, C. D.
(1996)
J. Biol. Chem.
271,
4627-4631[Abstract/Free Full Text]
|
| 39.
|
Mosior, M.,
and Epand, R. M.
(1993)
Biochemistry
32,
66-75[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Walker, J. M.,
and Sando, J. J.
(1989)
Adv. Exp. Med. Biol.
255,
29-36[Medline]
[Order article via Infotrieve]
|
| 41.
|
Giorgione, J. R.,
Huang, Z.,
and Epand, R. M.
(1998)
Biochemistry
37,
2384-2392[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Hinderliter, A. K.,
Dibble, A. R.,
Biltonen, R. L.,
and Sando, J. J.
(1997)
Biochemistry
36,
6141-6148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Sando, J. J.,
Chertihin, O. I.,
Owens, J. M.,
and Kretsinger, R. H.
(1998)
J. Biol. Chem.
273,
34022-34027[Abstract/Free Full Text]
|
| 44.
|
Sando, J. J.,
and Chertihin, O. I.
(1996)
Biochem. J.
317,
583-588
|
| 45.
|
Dimitrijevic, S. M.,
Ryves, W. J.,
Parker, P. J.,
and Evans, F. J.
(1995)
Mol. Pharmacol.
48,
259-267[Abstract]
|
| 46.
|
Newton, A. C.,
and Keranen, L. M.
(1994)
Biochemistry
33,
6651-6658[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Medkova, M.,
and Cho, W.
(1998)
Biochemistry
37,
4892-4900[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Takai, Y.,
Kishimoto, A.,
Iwasa, Y.,
Kawahara, Y.,
Mori, T.,
and Nishizuka, Y.
(1979)
J. Biol. Chem.
254,
3692-3695[Abstract/Free Full Text]
|
| 49.
|
Orr, J. W.,
and Newton, A. C.
(1994)
J. Biol. Chem.
269,
8383-8387[Abstract/Free Full Text]
|
| 50.
|
Bazzi, M. D.,
and Nelsestuen, G. L.
(1987)
Biochemistry
26,
5002-5008[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Rowe, E. S.,
and Campion, J. M.
(1994)
Biophys. J.
67,
1888-1895[Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Huang and Z. Zuo
Isoflurane Induces a Protein Kinase C {alpha}-Dependent Increase in Cell-Surface Protein Level and Activity of Glutamate Transporter Type 3
Mol. Pharmacol.,
May 1, 2005;
67(5):
1522 - 1533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Martinez, O. Vogler, J. Casas, F. Barcelo, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P. G. Kasprzyk, S. Teres, et al.
Membrane Structure Modulation, Protein Kinase C{alpha} Activation, and Anticancer Activity of Minerval
Mol. Pharmacol.,
February 1, 2005;
67(2):
531 - 540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Rebecchi and S. N. Pentyala
Anaesthetic actions on other targets:protein kinase C and guanine nucleotide-binding proteins
Br. J. Anaesth.,
July 1, 2002;
89(1):
62 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|